Cancer Vaccines Begin to Show Promise
By Malin Rising
Word Count: 955 | Companies Featured in This Article: Sanofi-Aventis, Roche Holding , GlaxoSmithKline, Merck KGaA, Genitope, Antigenics
COPENHAGEN -- After more than 20 years of setbacks, research into therapeutic cancer vaccines is starting to show promising results and attract the investments of large pharmaceutical firms. But the field remains risky, and so far no drugs have been approved for use.
About eight million people die from cancer each year, a figure that is expected to rise by 50% to approximately 12 million in 2030, making it the world's largest single killer disease, according to the World Health Organization.
Therapeutic vaccines stimulate the body's immune system to attack cancerous cells and leave healthy cells alive, while more traditional ...
also
Cancer Vaccines Attract Interest of Big Drug Firms
By Malin Rising
Word Count: 971 | Companies Featured in This Article: Sanofi-Aventis, Roche Holding , GlaxoSmithKline, Merck KGaA, Genitope, Antigenics
After more than 20 years of setbacks, research into therapeutic cancer vaccines is starting to show promising results and attract the investments of large pharmaceutical firms. But the field remains risky, and so far no drugs have been approved for use.
About eight million people die from cancer each year, a figure that is expected to rise by 50% to approximately 12 million in 2030, making it the world's largest single killer disease, according to the World Health Organization.
Therapeutic vaccines stimulate the body's immune system to attack cancerous cells and leave healthy cells alive, while more traditional cancer treatments ...
surf's up......crikey
